Mark McGovern

Queen's University Belfast
Queen's Management School
Riddel Hall
185 Stranmillis Road
BT95EE, Belfast
United Kingdom

E-Mail: EmailAddress: hidden: you can email any NBER-related person as first underscore last at nber dot org

NBER Working Papers and Publications

July 2017The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan, and South Korea
with David E. Bloom, Simiao Chen, Michael Kuhn, Les Oxley, Klaus Prettner: w23601
We propose a novel framework to analyse the macroeconomic impact of noncommunicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone gross domestic product (GDP). Unlike previously adopted frameworks, this approach allows us to account for i) variations in human capital for workers in different age groups, ii) mortality and morbidity effects of non-communicable diseases, and iii) the treatment costs of diseases. We apply our methodology to China, Japan, and South Korea, and estimate the economic burden of chronic conditions in five domains (cardiovascular diseases, cancer, respiratory diseases, diabetes, and mental health conditions)....
August 2013The Economic Impact of Non-Communicable Disease in China and India: Estimates, Projections, and Comparisons
with David E. Bloom, Elizabeth T. Cafiero, Klaus Prettner, Anderson Stanciole, Jonathan Weiss, Samuel Bakkila, Larry Rosenberg: w19335
This paper provides estimates of the economic impact of non-communicable diseases (NCDs) in China and India for the period 2012-2030. Our estimates are derived using WHO's EPIC model of economic growth, which focuses on the negative effects of NCDs on labor supply and capital accumulation. We present results for the five main NCDs (cardiovascular disease, cancer, chronic respiratory disease, diabetes, and mental health). Our undiscounted estimates indicate that the cost of the five main NCDs will total USD 27.8 trillion for China and USD 6.2 trillion for India (in 2010 USD). For both countries, the most costly domains are cardiovascular disease and mental health, followed by respiratory disease. Our analyses also reveal that the costs are much larger in China than in India mainly because o...

Published: The Journal of the Economics of Ageing Volume 4, December 2014, Pages 100–111 The Economic Implications of Population Ageing in China and India Cover image Full Length Article The macroeconomic impact of non-communicable diseases in China and India: Estimates, projections, and comparisons David E. Blooma, , , Elizabeth T. Cafiero-Fonsecag, , Mark E. McGoverna, b, , Klaus Prettnerc, , Anderson Stancioled, , Jonathan Weisse, f, , Samuel Bakkilag, , Larry Rosenbergg,

NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us